1. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension. Prewitt AR, Ghose S, Frump AL, Datta A, Austin ED, Kenworthy AK, de Caestecker MP (2015) J Biol Chem 290(2): 960-71
    › Primary publication · 25411245 (PubMed) · PMC4294523 (PubMed Central)
  2. Kidney regeneration: common themes from the embryo to the adult. Cirio MC, de Groh ED, de Caestecker MP, Davidson AJ, Hukriede NA (2014) Pediatr Nephrol 29(4): 553-64
    › Primary publication · 24005792 (PubMed) · PMC3944192 (PubMed Central)
  3. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus. Murphy AJ, Pierce J, de Caestecker C, Ayers GD, Zhao A, Krebs JR, Saito-Diaz VK, Lee E, Perantoni AO, de Caestecker MP, Lovvorn HN (2014) Oncotarget 5(2): 386-402
    › Primary publication · 24481423 (PubMed) · PMC3964215 (PubMed Central)
  4. A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury. Novitskaya T, McDermott L, Zhang KX, Chiba T, Paueksakon P, Hukriede NA, de Caestecker MP (2014) Am J Physiol Renal Physiol 306(5): F496-504
    › Primary publication · 24370591 (PubMed) · PMC3949031 (PubMed Central)
  5. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor. Murphy AJ, Pierce J, de Caestecker C, Libes J, Neblett D, de Caestecker M, Perantoni AO, Tanigawa S, Anderson JR, Dome JS, Das A, Carroll TJ, Lovvorn HN (2014) Pediatr Blood Cancer 61(2): 198-205
    › Primary publication · 24115727 (PubMed) · PMC3955491 (PubMed Central)
  6. Ischemia-reperfusion model of acute kidney injury and post injury fibrosis in mice. Skrypnyk NI, Harris RC, de Caestecker MP (2013) J Vis Exp (78)
    › Primary publication · 23963468 (PubMed) · PMC3854859 (PubMed Central)
  7. Histone deacetylase inhibitor enhances recovery after AKI. Cianciolo Cosentino C, Skrypnyk NI, Brilli LL, Chiba T, Novitskaya T, Woods C, West J, Korotchenko VN, McDermott L, Day BW, Davidson AJ, Harris RC, de Caestecker MP, Hukriede NA (2013) J Am Soc Nephrol 24(6): 943-53
    › Primary publication · 23620402 (PubMed) · PMC3665399 (PubMed Central)
  8. HDAC inhibitors in kidney development and disease. Brilli LL, Swanhart LM, de Caestecker MP, Hukriede NA (2013) Pediatr Nephrol 28(10): 1909-21
    › Primary publication · 23052657 (PubMed) · PMC3751322 (PubMed Central)
  9. Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux. Walker KA, Sims-Lucas S, Di Giovanni VE, Schaefer C, Sunseri WM, Novitskaya T, de Caestecker MP, Chen F, Bates CM (2013) PLoS One 8(2): e56062
    › Primary publication · 23409123 (PubMed) · PMC3567073 (PubMed Central)
  10. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension. Frump AL, Lowery JW, Hamid R, Austin ED, de Caestecker M (2013) PLoS One 8(11): e80319
    › Primary publication · 24224048 (PubMed) · PMC3818254 (PubMed Central)